TRU:NYSETransUnion Analysis
Data as of 2026-05-27 - not real-time
$71.20
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading below its 20‑day and 50‑day SMAs, with a bearish trend and decreasing volume, while the 30‑day volatility sits near 37% and beta exceeds 1.2, indicating heightened price swings. Valuation metrics show the market price (~$71) above the DCF‑derived fair value (~$64) and a trailing P/E (~20) that exceeds the industry average, suggesting the stock is currently overvalued.
Fundamental outlook: Despite the pricing pressure, TransUnion delivers solid revenue growth (~13% YoY), high gross margins (~59%), and a low payout ratio (~13%), supporting dividend sustainability. Forward earnings expectations compress the P/E to around 13, analysts maintain a "Buy" consensus with a target near $90, and a recent partnership with Google highlights growth potential in data‑driven marketing solutions.
Fundamental outlook: Despite the pricing pressure, TransUnion delivers solid revenue growth (~13% YoY), high gross margins (~59%), and a low payout ratio (~13%), supporting dividend sustainability. Forward earnings expectations compress the P/E to around 13, analysts maintain a "Buy" consensus with a target near $90, and a recent partnership with Google highlights growth potential in data‑driven marketing solutions.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical positioning (price below SMAs, decreasing volume)
- Current price above fair value
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward P/E discount to industry peers
- Strong revenue growth and high operating margins
- Analyst consensus buy with upside potential toward $90 target
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic partnership with Google expanding data solutions
- Sustainable dividend backed by robust cash flow
- Recurring, high‑margin credit and analytics business model
Key Metrics & Analysis
Financial Health
Revenue Growth13.70%
Profit Margin14.90%
P/E Ratio19.7
ROE15.25%
ROA4.65%
Debt/Equity115.67
P/B Ratio3.1
Op. Cash Flow$1.0B
Free Cash Flow$749.8M
Industry P/E16.7
Technical Analysis
TrendBearish
RSI53.3
Support$64.51
Resistance$73.62
MA 20$69.43
MA 50$70.59
MA 200$79.46
MACDBullish
VolumeDecreasing
Fear & Greed Index91.11
Valuation
Fair Value$64.04
Target Price$90.19
Upside/Downside26.68%
GradeOvervalued
TypeBlend
Dividend Yield0.71%
Risk Assessment
Beta1.25
Volatility36.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.